Personalizing Treatment: Mutations Identified in Squamous Cell Lung Cancer Tumors

VIDEO | 04:00

Screening lung cancer tumor samples for cancer-causing, or "driver," genetic mutations can help in tailoring treatments to target those specific mutations. Medical oncologist Paul Paik discusses the Squamous Cell Carcinoma of the Lung Mutation Analysis Program (SQ-MAP) and various clinical trials now being offered to patients with this condition.